Yahoo Canada Web Search

Search results

1. beximco-pharma.com › cdn › bplFirst Quarter Report 2022-2023 - beximco-pharma.com

   beximco-pharma.com › cdn › bpl

   The Dividend Payable/Unclaimed dividend as on September 30, 2022 includes Tk. 44,812K relating to year 2020-21 which has been paid but not yet claimed. The remaining balance relates to dividend for prior years unclaimed to date. For the Period For the Period July - September 2022 July - September 2021. 10.

2. www.beximco.com › annual-report-2022-23www.beximco.com

   www.beximco.com › annual-report-2022-23

   www.beximco.com

3. www.beximcopharma.com › investorsBeximco Pharmaceuticals Ltd.

   www.beximcopharma.com › investors

   Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. BPL is the largest exporter of generic drugs in the country and its state-of-the-art manufacturing facilities are already certified by major global regulatory authorities like TGA, GCC and ANVISA, while awaiting audits and approvals by US FDA ...

4. www.investing.com › equities › beximcoBeximco Pharmaceuticals Ltd (BXPH) - Investing.com

   www.investing.com › equities › beximco

   • Cached

   Get free historical data for BXPH. You'll find the closing price, open, high, low, change and %change of the Beximco Pharmaceuticals Ltd Stock for the selected range of dates. The data can be ...

5. www.marketscreener.com › quote › stockFinancials Beximco Pharmaceuticals Limited - MarketScreener.com

   www.marketscreener.com › quote › stock

   • Cached

   5 days ago · Beximco Pharmaceuticals Limited: Forcasts, revenue, earnings, analysts expectations, ratios for Beximco Pharmaceuticals Limited Stock | BXPHARMA | BD0453BXPH04

6. www.investing.com › equities › beximcoBeximco Pharmaceuticals Ltd (BXPH) - Investing.com

   www.investing.com › equities › beximco

   • Cached

   Net income was BDT 4,350.9 million compared to BDT 3,634.59 million a year ago. Basic earnings per share from continuing operations was BDT 9.75 compared to BDT 8.15 a year ago. View advanced ...

7. People also ask

   Who is Beximco Pharmaceuticals Limited?

   • Beximco Pharmaceuticals Limited (Beximco Pharma/BPL/ the Company) is a public limited company incorporated in Bangladesh in 1976. It is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company was listed with Dhaka Stock Exchange in 1985 and with Chittagong Stock Exchange on its debut in 1995.

   First Quarter Report 2022-2023 - Beximco Pharmaceuticals Ltd

   beximco-pharma.com/cdn/bpl/investor/pdf/first-quarter-report-2022-2023.pdf

   See all results for this question

   Which subsidiaries have been consolidated with Beximco Pharmaceuticals Limited?

   • The financial statements of the subsidiaries-Nuvista Pharma Limited, Synovia Pharma PLC and Beximco Pharma API Limited, have been consolidated with those of Beximco Pharmaceuticals Limited in accordance with IFRS 10: Consolidated Financial Statements. The Company acquired 85.22% shares of the issued and paid up capital of Nuvista Pharma Limited.

   First Quarter Report 2022-2023 - Beximco Pharmaceuticals Ltd

   beximco-pharma.com/cdn/bpl/investor/pdf/first-quarter-report-2022-2023.pdf

   See all results for this question

   Who owns Beximco infusions Ltd?

   • In 2005, BPL took over Beximco Infusions Ltd., a listed company engaged in manufacturing and marketing of intravenous fluids and got enlisted with the Alternative Investment Market (AIM) of the London Stock Exchange through issuance of Global Depository Receipts (GDRs).

   First Quarter Report 2022-2023 - Beximco Pharmaceuticals Ltd

   beximco-pharma.com/cdn/bpl/investor/pdf/first-quarter-report-2022-2023.pdf

   See all results for this question

8. www.marketscreener.com › quote › stockBeximco Pharmaceuticals Limited: Financial Data Forecasts ...

   www.marketscreener.com › quote › stock

   • Cached

   Aug 21, 2024 · Beximco Pharmaceuticals Limited: Forcasts, revenue, earnings, analysts expectations, ratios for Beximco Pharmaceuticals Limited Stock | BXP | US0885792061 b3d2254a71ed6f219193c687676a4.PMmwWNHdxrDD4sHhUnVBVLUo_BeDF3G9384I-DJ0Nsc.a7qECri4oty0s_ilIQ0oGcwYtmSzSCbUlaN_sEUrD5hLpcIhqayQ_qyvsg